Clemens Wittenbecher

Recent advances in precision nutrition and cardiometabolic diseases

Lifetime Duration of Breastfeeding and Cardiovascular Risk in Women With Type 2 Diabetes or a History of Gestational Diabetes: Findings From Two Large Prospective Cohorts

Deciphering lipoprotein(a) atherogenicity with use of high-throughput proteomics

Plasma metabolite predictors of metabolic syndrome incidence and reversion

2024

Plasma metabolites of a healthy lifestyle in relation to mortality and longevity: Four prospective US cohort studies

2024

Lipidome changes due to improved dietary fat quality inform cardiometabolic risk reduction and precision nutrition

Broadcasters, receivers, functional groups of metabolites, and the link to heart failure by revealing metabolomic network connectivity

Blood lipid profiling indicates that dietary fat quality is associated with cardiometabolic risk

Plasma Lipidomic n-6 Polyunsaturated Fatty Acids and Type 2 Diabetes Risk in the EPIC-Potsdam Prospective Cohort Study

2023

Plasma lipidome and risk of atrial fibrillation: results from the PREDIMED trial

2023

Plasma metabolomic profiles associated with mortality and longevity in a prospective analysis of 13,512 individuals

2023

Low-Carbohydrate Diet Scores and Mortality Among Adults With Incident Type 2 Diabetes

2023

Mapping of the gene network that regulates glycan clock of ageing

2023

Circulating Amino Acids and Risk of Peripheral Artery Disease in the PREDIMED Trial

2023

Replacement of dietary saturated with unsaturated fatty acids is associated with beneficial effects on lipidome metabolites: a secondary analysis of a randomized trial

2022

Immunoglobulin G N-Glycosylation Signatures in Incident Type 2 Diabetes and Cardiovascular Disease

2022

Retinol and Retinol Binding Protein 4 Levels and Cardiometabolic Disease Risk